Interaction Guide · Research summary

Can I take Vitamin D with Fludrocortisone?

Review Vitamin D with Fludrocortisone: timing and monitoring, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Fludrocortisone alone does not establish a need for extra vitamin D or a special dosing interval. Review bone health and overall steroid treatment with your clinician, particularly if you also take a systemic glucocorticoid.

What this answer covers

Vitamin D during oral fludrocortisone acetate mineralocorticoid replacement. Concurrent glucocorticoid dose and bone risk must be assessed separately.

Supplement or preparation
Vitamin D
Medication ingredient
fludrocortisone

Which treatment this applies to

This review concerns oral fludrocortisone acetate tablets, the preparation used clinically for fludrocortisone’s mineralocorticoid effects. Adrenal replacement and treatment of orthostatic symptoms require distinct salt and monitoring plans. It does not establish free-base dose equivalence or effects of other routes.

Mineralocorticoid replacement differs

Fludrocortisone is used for its strong mineralocorticoid effects. Bone recommendations for prolonged systemic glucocorticoid treatment cannot be transferred solely because both medicines are called steroids. Your other hormone replacements and their doses matter.

Bone health still deserves appropriate follow-up

NICE adrenal-insufficiency guidance includes bone-density assessment in adult follow-up. The ACR guideline supports adequate calcium and vitamin D intake for applicable systemic glucocorticoid exposure. Neither source shows that every fludrocortisone user develops vitamin D deficiency or needs a larger dose.

Choose supplementation for an identified need

Discuss usual intake, existing supplements, relevant test results and fracture risk. If vitamin D is prescribed, follow that plan; these sources do not establish a fludrocortisone-specific dose gap or replacement amount. Do not change essential hormone treatment to address an assumed nutrient interaction.

Evidence and practical considerations

Timing & monitoring

No exact evidence establishes an increased vitamin D requirement from usual fludrocortisone mineralocorticoid replacement.

Exact scope
Vitamin D during oral fludrocortisone acetate mineralocorticoid replacement. Concurrent glucocorticoid dose and bone risk must be assessed separately. with Exact RxNorm 4452 IN fludrocortisone. Clinical label evidence is oral fludrocortisone acetate 0.1 mg tablets, the ester preparation used for mineralocorticoid effects; this is an explicit active-moiety bridge, not a free-base dose equivalence.
Medication form and route
Oral

What remains uncertain

  • No exact fludrocortisone-vitamin D requirement or timing study. Systemic glucocorticoid guidance and adrenal follow-up support assessment, not automatic class transfer to mineralocorticoid replacement.

Factors that may matter: Exact oral preparation and dose; Treatment duration and indication; Blood pressure and electrolyte status; Other medicines.

Research conclusion: insufficient evidence · Evidence assessment: low

Read the supporting source summaries

Source 1: Current prescribing information

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Patients prescribed Fludrocortisone acetate oral tablets.

Small oral doses cause sodium retention, increased potassium excretion and BP elevation. Monitoring of salt intake, BP, weight and electrolytes is advised; replacement decisions are individualized.

How this applies: Exact ingredient and specified formulation. Exact RxNorm 4452 IN fludrocortisone. Clinical label evidence is oral fludrocortisone acetate 0.1 mg tablets, the ester preparation used for mineralocorticoid effects; this is an explicit active-moiety bridge, not a free-base dose equivalence.

Acetate formulation bridge does not establish other routes or dose equivalence. Mineralocorticoid replacement is not automatically the systemic glucocorticoid exposure in osteoporosis guidelines.

Source 2: Original specialty-society guideline

endocrine.org · Source check Sep 10, 2026

Population: Patients with primary adrenal insufficiency and documented hormone deficiencies.

Advises not routinely restricting salt with mineralocorticoid replacement; monitors symptoms, BP and electrolytes and adjusts treatment if hypertension occurs.

How this applies: Exact replacement context and distinction between mineralocorticoid and glucocorticoid exposure.

Replacement-indication guidance, not every anti-inflammatory steroid course or every salt supplement. No automatic vitamin D requirement.

Source 3: Original national clinical guideline

nice.org.uk · Source check Sep 10, 2026

Population: People with adrenal insufficiency.

Persistent hyponatremia despite maximum fludrocortisone may warrant sodium chloride supplementation. Follow-up includes BP, electrolytes and bone-density assessment in adults.

How this applies: Indication-specific management, not general salt avoidance or automatic vitamin replacement.

Not a demonstration that fludrocortisone universally depletes vitamin D or requires a dose gap. Original HTML accessed successfully despite browser403.

Source 4: Original professional guideline

acrjournals.onlinelibrary.wiley.com · Source check Sep 10, 2026

Population: Patients receiving systemic glucocorticoids, with dose-duration and fracture-risk stratification.

Recommends adequate age-appropriate calcium and vitamin D intake and risk-based bone assessment; higher-risk patients may need osteoporosis medicines.

How this applies: Conditional applicability based on actual systemic glucocorticoid dose, duration and risk.

Calcium/vitamin D alone have low or very-low certainty fracture-prevention evidence. Not an exact fludrocortisone nutrient trial or automatic supplement need. Mineralocorticoid replacement is not assumed to meet systemic glucocorticoid thresholds.

Source 5: Medication terminology

rxnav.nlm.nih.gov · Source check Sep 10, 2026

Population: Terminology.

fludrocortisone is IN.

How this applies: Exact ingredient.

Not clinical evidence.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Sources checked and article drafted.
Research summary published

Article revision: f05d483a613d18ac

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.